Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?
Offered By: Brown University via Independent
Course Description
Overview
Jennifer B. Dwyer, MD, PhD
Co-Director Yale Pediatric Depression Program
Assistant Professor, Child Study Center and Dept of Radiology and Biomedical Imaging
Yale University
Syllabus
- Describe the proposed mechanism of action of novel rapid-acting anti-depressant and anti-suicidal pharmacotherapeutics
- Describe the state of the pediatric evidence base for rapid-acting treatments and to compare it with the adult evidence base
- Appreciate the unique developmental considerations that apply to testing and implementing novel therapeutics in the pediatric population
Tags
Related Courses
Antimicrobial Stewardship: Optimization of Antibiotic PracticesStanford University via Coursera Teaching and Assessing Clinical Skills
University of Michigan via Coursera Medicating for Mental Health: Judicious Use of Psychiatric Drugs
Colgate University via edX Improving the Health of Women, Children and Adolescents: from Evidence to Action
London School of Hygiene & Tropical Medicine via FutureLearn Health Technology Assessment: Choosing Which Treatments Get Funded
The University of Sheffield via FutureLearn